Stock listing
BOATS:LABT Lakewood-Amedex Biotherapeutics Inc. Stock
US listing (BOATS) of Lakewood-Amedex Biotherapeutics Inc. · home listing NASDAQ:LABT
Follow Lakewood-Amedex Biotherapeutics Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:LABT
$0.24 USD +0.03 (+11.9%)
Close on Nov 18, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LABT
- Day range
- $0.192 – $0.308 USDNov 18, 2026
- Volume
- 5.04M sharesNov 18, 2026
- Market cap
- $568,725 USDAt the close on Nov 18, 2026 · price × 2.37M shares outstanding
- Traded on an average day
- $8.67M USDMedian day 283,900 shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LABT · Home | $0.24 USD | +0.025 (+11.9%) | 5,039,832 | $0.227 | $0.308 | $0.192 | $0.215 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:LABT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.24 | +0.025 | +11.9% | $0.227 | $0.308 | $0.192 | 5,039,832 | |
| $0.215 | -0.005 | -2.2% | $0.207 | $0.269 | $0.204 | 1,977,326 | |
| $0.219 | -0.063 | -22.3% | $0.258 | $0.259 | $0.212 | 874,059 | |
| $0.282 | -0.077 | -21.4% | $0.334 | $0.339 | $0.24 | 2,024,462 | |
| $0.359 | -0.041 | -10.2% | $0.373 | $0.39 | $0.35 | 1,159,890 | |
| $0.40 | -0.02 | -4.8% | $0.41 | $0.44 | $0.36 | 2,731,700 | |
| $0.42 | 0.00 | 0.0% | $0.36 | $0.44 | $0.35 | 4,376,800 | |
| $0.42 | +0.03 | +7.7% | $0.44 | $0.45 | $0.37 | 13,547,700 | |
| $0.39 | -0.15 | -27.8% | $0.44 | $0.49 | $0.33 | 36,109,700 | |
| $0.54 | +0.35 | +184.2% | $0.38 | $0.96 | $0.37 | 753,749,700 | |
| $0.19 | -0.01 | -5.0% | $0.19 | $0.20 | $0.17 | 809,100 | |
| $0.20 | +0.01 | +5.3% | $0.18 | $0.20 | $0.17 | 880,800 | |
| $0.19 | -0.01 | -5.0% | $0.19 | $0.20 | $0.17 | 1,361,400 | |
| $0.20 | -0.04 | -16.7% | $0.20 | $0.22 | $0.20 | 1,935,900 | |
| $0.24 | -0.05 | -17.2% | $0.24 | $0.24 | $0.22 | 4,128,300 | |
| $0.29 | 0.00 | 0.0% | $0.28 | $0.29 | $0.25 | 24,887,400 | |
| $0.29 | +0.01 | +3.6% | $0.25 | $0.29 | $0.24 | 1,423,200 | |
| $0.28 | -0.03 | -9.7% | $0.27 | $0.28 | $0.24 | 2,789,800 | |
| $0.31 | -0.18 | -36.7% | $0.35 | $0.36 | $0.28 | 40,069,500 | |
| $0.49 | +0.02 | +4.3% | $0.47 | $0.51 | $0.46 | 328,400 | |
| $0.47 | -0.11 | -19.0% | $0.55 | $0.58 | $0.42 | 658,900 | |
| $0.58 | 0.00 | 0.0% | $0.58 | $0.62 | $0.57 | 99,600 | |
| $0.58 | 0.00 | 0.0% | $0.58 | $0.67 | $0.56 | 93,100 | |
| $0.58 | -0.03 | -4.9% | $0.63 | $0.63 | $0.58 | 65,600 | |
| $0.61 | -0.02 | -3.2% | $0.60 | $0.63 | $0.58 | 148,300 | |
| $0.63 | -0.06 | -8.7% | $0.67 | $0.71 | $0.62 | 133,900 | |
| $0.69 | -0.04 | -5.5% | $0.73 | $0.73 | $0.67 | 152,700 | |
| $0.73 | -0.05 | -6.4% | $0.77 | $0.77 | $0.73 | 160,700 | |
| $0.78 | -0.01 | -1.3% | $0.79 | $0.82 | $0.78 | 118,100 | |
| $0.79 | -0.06 | -7.1% | $0.82 | $0.83 | $0.78 | 216,800 | |
| $0.85 | -0.02 | -2.3% | $0.78 | $0.90 | $0.76 | 8,498,700 | |
| $0.87 | +0.02 | +2.4% | $0.86 | $0.87 | $0.83 | 149,700 | |
| $0.85 | -0.08 | -8.6% | $0.88 | $0.89 | $0.82 | 272,200 | |
| $0.93 | 0.00 | 0.0% | $0.93 | $0.95 | $0.91 | 120,500 | |
| $0.93 | -0.03 | -3.1% | $0.94 | $0.96 | $0.91 | 170,300 | |
| $0.96 | -0.03 | -3.0% | $0.97 | $0.98 | $0.92 | 401,800 | |
| $0.99 | -0.16 | -13.9% | $1.09 | $1.09 | $0.92 | 1,288,600 | |
| $1.15 | -0.52 | -31.1% | $2.06 | $2.13 | $1.10 | 35,362,700 | |
| $1.67 | -0.16 | -8.7% | $1.85 | $1.85 | $1.63 | 176,000 | |
| $1.83 | +0.05 | +2.8% | $1.76 | $1.85 | $1.69 | 101,500 | |
| $1.78 | -0.21 | -10.6% | $1.97 | $2.00 | $1.78 | 109,800 | |
| $1.99 | -0.06 | -2.9% | $2.08 | $2.10 | $1.90 | 128,400 | |
| $2.05 | +0.06 | +3.0% | $1.99 | $2.08 | $1.92 | 361,800 | |
| $1.99 | +0.13 | +7.0% | $1.92 | $2.15 | $1.89 | 281,200 | |
| $1.86 | -0.23 | -11.0% | $2.04 | $2.05 | $1.84 | 125,200 | |
| $2.09 | -0.08 | -3.7% | $2.18 | $2.18 | $2.08 | 54,500 | |
| $2.17 | +0.05 | +2.4% | $2.17 | $2.17 | $2.07 | 97,300 | |
| $2.12 | -0.10 | -4.5% | $2.25 | $2.28 | $2.06 | 56,400 | |
| $2.22 | +0.17 | +8.3% | $2.11 | $2.23 | $2.03 | 141,000 | |
| $2.05 | -0.27 | -11.6% | $2.24 | $2.30 | $2.03 | 286,600 | |
| $2.32 | +0.14 | +6.4% | $2.20 | $2.61 | $2.13 | 5,084,500 | |
| $2.18 | +0.30 | +16.0% | $1.89 | $2.27 | $1.89 | 500,000 | |
| $1.88 | -0.02 | -1.1% | $1.88 | $1.98 | $1.87 | 90,200 | |
| $1.90 | -0.17 | -8.2% | $2.10 | $2.16 | $1.86 | 251,200 | |
| $2.07 | -0.69 | -25.0% | $2.47 | $2.64 | $2.06 | 509,100 | |
| $2.76 | +0.26 | +10.4% | $2.68 | $2.86 | $2.53 | 3,568,500 | |
| $2.50 | +0.20 | +8.7% | $2.23 | $2.58 | $2.22 | 13,655,500 | |
| $2.30 | -0.19 | -7.6% | $2.44 | $2.44 | $2.22 | 95,800 | |
| $2.49 | +0.04 | +1.6% | $2.62 | $2.62 | $2.35 | 213,500 | |
| $2.45 | +0.16 | +7.0% | $2.23 | $2.57 | $2.20 | 377,200 | |
| $2.29 | +0.16 | +7.5% | $2.10 | $2.35 | $2.10 | 213,343 | |
| $2.13 | -0.11 | -4.9% | $2.20 | $2.29 | $2.10 | 39,957 | |
| $2.24 | +0.05 | +2.3% | $2.18 | $2.34 | $2.17 | 70,500 | |
| $2.19 | -0.05 | -2.2% | $2.17 | $2.24 | $2.13 | 85,100 | |
| $2.24 | -0.06 | -2.6% | $2.23 | $2.35 | $2.16 | 80,200 | |
| $2.30 | +0.14 | +6.5% | $2.14 | $2.30 | $2.04 | 102,300 |
Splits
1 split · NASDAQ:LABT · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- BOATS:LABT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption
Latest deck · Oct 21, 2026
Investor Presentation (October 2026)
Investor deck · 22 slides
Latest news
Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption
Nov 5, 2026
Closed $0.54 (+184.2%) on Nov 5, 2026
Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026
Oct 21, 2026
Closed $0.47 (-19.0%) on Oct 21, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
Oct 7, 2026
Closed $0.85 (-2.3%) on Oct 7, 2026
Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
Oct 1, 2026
Closed $0.93 (-3.1%) on Oct 1, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
Sep 28, 2026
Closed $1.15 (-31.1%) on Sep 28, 2026
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
Sep 21, 2026
Closed $2.05 (+3.0%) on Sep 21, 2026
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
Sep 18, 2026
Closed $1.99 (+7.0%) on Sep 18, 2026
Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $2.18 (+16.0%) on Sep 8, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 22 slides · Oct 21, 2026
Investor Presentation (September 2026)
Investor deck · 21 slides · Sep 25, 2026
Investor Presentation (July 2026)
Investor deck · 21 slides · Jul 15, 2026
Lakewood-Amedex — Investor Presentation (September 2014)
Investor deck · 31 slides · September 2014
Lakewood-Amedex Biotherapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 20 in all · newest Nov 5, 2026 · oldest 2026
- Decks
- 4 decks · latest Oct 21, 2026
Where Lakewood-Amedex Biotherapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LABT · Home listing | NASDAQ | United States | USD |
| BOATS:LABT · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lakewood-Amedex Biotherapeutics Inc.